Motley Fool Australia

Healius Ltd (ASX: HLS) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Healius Ltd (ASX: HLS) Latest News

broker Buy Shares

Top brokers name 3 ASX shares to buy next week

More »

broker Buy Shares

Brokers name 3 ASX shares to buy right now

More »

wooden letter blocks spelling the word 'discount' representing cheap xero share price

2 dirt cheap ASX shares to buy in 2021

More »

two hands wearing medical gloves make the shape of a heart, indicating the best healthcare shares on the ASX market

These are 8 of the best performing ASX healthcare shares of 2020 so far

More »

broker Buy Shares

Top brokers name 3 ASX shares to buy next week

More »

asx brokers

Goldman Sachs names Healius (ASX:HLS) as a value share to buy

More »

Young man looking afraid representing ASX shares investor scared of market crash

5 things to watch on the ASX 200 on Thursday

More »

Female ASX investor standing with back to camera, reviewing screen of share price charts in front of her

ASX 200 up 0.7%: CBA update, IGO enters lithium market, Healius jumps

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Healius Ltd (ASX: HLS)

Healius Ltd (HLS) is an Australian healthcare company with operations in 3 main business segments: pathology, medical centres and imaging. On top of this, Healius also has 3 emerging business segments: dental, IVF and day hospitals.

With this, Healius provides diagnostic services to consumers and referring practitioners, and enables healthcare professionals to deliver patient care in partnership with the company’s nurses and support staff. Healius has a 13,000-strong workforce and a market-leading network consisting of pathology laboratories, collection centres, medical centres, day hospitals and imaging sites located throughout Australia.

Healius was formerly known as Primary Health Care and traded on the ASX under the ticker code PRY. In 2018, it rebranded as Healius to, according to the company, better align with its services, people and future.

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
10 Dec 2020 Robert Hubbard Issued 21 $75,000
10 Dec 2020 Paul Jones Issued 8 $30,000
10 Dec 2020 Sally Evans Issued 10 $37,500
10 Nov 2020 Jennifer (Jenny) Macdonald Buy 15 $52,650
14 Aug 2020 Malcolm Parmenter Expiry 475 $1,511,072
01 Jul 2020 Malcolm Parmenter Exercise 26 $82,264
01 Jul 2020 Malcolm Parmenter Issued 26 $82,264
03 Mar 2020 Malcolm Parmenter Issued 11 $33,354,986
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Robert Hubbard Non-Executive Director,Non-Executive Chairman Dec 2014
Dr Malcolm Parmenter Chief Executive Officer,Managing Director Sep 2017
Mr Gordon Richard Davis Non-Executive Director Aug 2015
Dr Paul Francis Jones Non-Executive Director Nov 2010
Ms Jennifer (Jenny) Mitchell Macdonald Non-Executive Director Nov 2020
Ms Sally Evans Non-Executive Director Aug 2018
Ms Alison Stephenson Company Secretary Aug 2019
Mr Charles Tilley Company Secretary Feb 2015
Ben Korst Chief Executive Day Hospitals
Dean Lewsam Chief Executive Imaging
Scott Beattie Chief Executive Medical Centres
John McKechnie Chief Executive Pathology
Maxine Jaquet Chief Financial Officer
Alison Stephenson Company Secretary
Charles Tilley Company Secretary
Janet Payne Group Executive Corporate Affairs
Mark Neeham Group Executive Government & External Affairs
Peter Wilson Group Executive People & Shared Services
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 174,206,628 27.96%
Jangho Health Care Australia Pty Ltd and its related bodies corporate 98,946,666 15.88%
J P Morgan Nominees Australia Pty Limited 94,180,700 15.12%
Citicorp Nominees Pty Limited 65,727,145 10.55%
National Nominees Pty Ltd 53,339,969 8.56%
Argo Investments Limited 13,820,664 2.22%
BNP Paribas Noms Pty Ltd <DRP> 12,248,730 1.97%
BNP Paribas Nominees Pty Ltd <Agency Lending DRP A/C> 9,986,725 1.60%
HSBC Custody Nominees (Australia) Limited <NT Comnwlth Super Corp A/C> 7,347,317 1.18%
UBS Nominees Pty Ltd 6,174,498 0.99%
HSBC Custody Nominees (Australia) Limited GSCO ECA 2,864,847 0.46%
Citicorp Nominees Pty Ltd <Colonial First State Inv A/C> 2,468,936 0.40%
RinRim Pty Ltd 2,392,047 0.38%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <DRP A/C> 1,175,335 0.19%
Nulis Nominees (Australia) Limited <Navigator Mast Plan Sett A/C> 900,643 0.14%
Navigator Australia Ltd <MLC Investments Sett A/C> 856,037 0.14%
Joromada Pty Ltd 800,000 0.13%
Hsbc Custody Nominees (Australia) Limited I 719,614 0.12%
Netwealth Investments Limited <WRAP Services A/C> 645,615 0.10%
Mr Gregory Anthony Thomas Bateman 636,213 0.10%
Show more